NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.